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Far red/near-infrared light (NIR) promotes a wide range of biological effects including
tissue protection but whether and how NIR is capable of acutely protecting myocardium
against ischemia and reperfusion injury in vivo is not fully elucidated. Our previous work
indicates that NIR exposure immediately before and during early reperfusion protects the
myocardium against infarction through mechanisms that are nitric oxide (NO)-dependent.
Here we tested the hypothesis that NIR elicits protection in a diabetic mouse model
where other cardioprotective interventions such as pre- and postconditioning fail, and
that the protection is independent of nitric oxide synthase (NOS). NIR reduced infarct
size dose dependently. Importantly, NIR-induced protection was preserved in a diabetic
mouse model (db/db) and during acute hyperglycemia, as well as in endothelial NOS−/−
mice and in wild type mice treated with NOS inhibitor L-NAME. In in vitro experiments
NIR light liberates NO from nitrosyl hemoglobin (HbNO) and nitrosyl myoglobin (MbNO) in
a wavelength-(660-830 nm) and dose-dependent manner. Irradiation at 660 nm yields the
highest release of NO, while at longer wavelengths a dramatic decrease of NO release
can be observed. Similar wavelength dependence was observed for the protection of
mice against cardiac ischemia and reperfusion injury in vivo. NIR-induced NO release
from deoxymyoglobin in the presence of nitrite mildly inhibits respiration of isolated
mitochondria after hypoxia. In summary, NIR applied during reperfusion protects the
myocardium against infarction in an NO-dependent, but NOS-independent mechanisms,
whereby mitochondria may be a target of NO released by NIR, leading to reduced
reactive oxygen species generation during reperfusion. This unique mechanism preserves
protection even during diabetes where other protective strategies fail.
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INTRODUCTION
Restoration of blood flow to a region of previously ischemic
myocardium (reperfusion) is a critical life-saving intervention
against tissue necrosis, but reperfusion itself also results in
significant damage to the myocardium. Many therapeutic strate-
gies such as ischemic and volatile anesthetic pre- and postcondi-
tioning have been developed and are effective in healthy animal
models but few have translated successfully to patients (Ludman
et al., 2010). A major reason for the resistance to cardioprotec-
tion against infarction by physical or pharmacological stimuli is
the advanced age and/or presence of comorbidities such as dia-
betes in patients. For example, endothelial dysfunction appears
to contribute to the lack of protection by ischemic or anesthetic
postconditioing in diabetes (Raphael et al., 2010; Przyklenk et al.,
2011). Activation of endothelial nitric oxide synthase (eNOS) and
pro-survival signaling pathways, together with alteration of mito-
chondrial bioenergetics, contribute to the mechanisms of vari-
ous cardioprotective strategies against ischemia and reperfusion
injury (Tsang et al., 2004; Mio et al., 2009; Ge et al., 2010).
Although nitric oxide synthases (NOS) produce a large part of
endogenous nitric oxide (NO), there is considerable interest in
NOS-independent generation of NO in vivo, particularly during
hypoxia or anoxia, where low oxygen tensions limit NOS activity
(Godecke, 2006; Hendgen-Cotta et al., 2008, 2010). Interventions
that can increase NO bioavailability have significant therapeutic
potential. Under hypoxic conditions, heme-containing proteins
such as myoglobin (Mb) and hemoglobin (Hb) exhibit nitrite
reductase activity which results in an increase in NO bound to the
heme iron of Mb and Hb (Gladwin et al., 2006; Hendgen-Cotta
et al., 2008). We have recently found that far red/near infrared
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light (NIR) both in purified systems and in myocardium can
release NO from nitrosyl hemes (Lohr et al., 2009). Further, NIR
protected cardiomyocytes and the rabbit heart from hypoxia and
reoxygenation injury in a NO-dependent manner, reversible by
NO scavenger cPTIO, and enhanced the protective effect of nitrite
against ischemia and reperfusion injury of the rabbit heart (Lohr
et al., 2009; Zhang et al., 2009).
NIR modulates biochemical systems by activating light-
sensitive proteins harboring NIR-sensitive chromophores (Karu,
1999; Desmet et al., 2006). Previous studies suggested that NIR
promotes cell survival during physiologic stress (Eells et al., 2003;
Liang et al., 2008; Zhang et al., 2009). Repeated photostimula-
tion of the myocardium has been demonstrated to be beneficial
against long-term reperfusion injury in the rat and dog (Oron
et al., 2001). For example, low-energy infrared (803 nm) laser
irradiation delivered to the epicardium was shown to reduce scar
formation and myocardial infarct size several weeks after pro-
longed coronary artery occlusion in dogs and rats (Oron et al.,
2001). Aside from the heart, the beneficial effects of NIR light
treatment have been studied in particular in a model of traumatic
brain injury as well as in wound healing (Ankri et al., 2010; Naeser
et al., 2011). NIR light treatment also improved the collateral
blood vessel grow in a mouse model (tight skin mouse) of scle-
roderma (Zaidi et al., 2013). Frequently, the beneficial effects of
NIR treatment have been associated with the stimulation of mito-
chondrial metabolism, particularly at the level of cytochrome c
oxidase, complex IV of the electron transport chain (Karu, 2008).
However, in a model of cardiac ischemia and reperfusion injury
it is difficult to perceive how acceleration of cytochrome c oxi-
dase at the time of reperfusion conveys protection to the heart.
Rather, a mild reversible inhibition of the electron transport chain
has been shown to reduce reactive oxygen species production
during reperfusion, thereby increasing cardiomyocyte survival
(Burwell et al., 2009). NO inhibits electron transport through
competitive binding at complex IV and S-nitrosation at complex
I (Piantadosi, 2012; Chouchani et al., 2013). Thus, we tested the
hypothesis that brief exposure to NIR light at the time of reper-
fusion protects the heart in a wave length-dependent manner;
and that this wave length dependence is paralleled by the release
of NO from nitrosyl-heme proteins. We also examined whether
NIR induced protection is maintained in a mouse model of acute
hyperglycemia and diabetes (db/db) where protection by volatile
anesthetics fail.
MATERIALS AND METHODS
All experimental procedures and protocols used in this investiga-
tion were reviewed and approved by the Animal Care and Use
Committee of the Medical College of Wisconsin. Furthermore,
all conformed to the Guiding Principles in the Care and Use
of Animals of the American Physiologic Society and were in
accordance with the Guide for the Care and Use of Laboratory
Animals.
MYOCARDIAL ISCHEMIA AND REPERFUSION INJURY IN MICE
A murine model of myocardial ischemia and reperfusion injury
was used as previously described (Ge et al., 2010). C57Bl/6
(wild type) mice, as well as eNOS−/− and diabetic db/db mice
were used for these experiments. Glucose (2 g/kg) was adminis-
tered intraperitoneal 10min before ischemia to produce hyper-
glycemia. Mice were anesthetized by intraperitoneal injection of
sodium pentobarbital (100mg/kg) and ventilated with room air
supplemented with 100 % oxygen at a rate of 100 breaths/min
with a tidal volume of approximately 0.25ml using a rodent
ventilator (Harvard Apparatus, South Natick, MA). Body temper-
ature was maintained between 36.8 ◦C and 37.5 ◦C. Myocardial
ischemia was produced by occluding the left coronary artery
(LAD) for 30min, and reperfusion was initiated by loosening the
suture and continued for 3 h.
EXPERIMENTAL PROTOCOL
Mice were randomly assigned to receive no irradiation (con-
trol) or NIR irradiation applied to the epicardial surface
(670 nm, 170mW/cm2) with an LED array (NIR Products
LLC, Milwaukee, WI) for 1min before and through the first
4min of reperfusion (energy-density equivalent to 51 J/cm2).
Separate experiments were performed to evaluate the energy-
and wavelength-dependence of NIR-mediated cardioprotection
by varying the array (670, 740, 830 nm) and the output of the
device.
C57BL/6, eNOS−/− mice and db/dbmice were used to explore
the dependence of NIR-mediated cardioprotection on eNOS and
its efficacy in a diabetic animal.Acute hyperglycemia was induced
by administration of D-glucose (2 g/kg) in C57BL/6 mice 10min
before ischemia. Mannitol (1.82 g/kg) was used for osmotic con-
trol in preliminary experiments in C57BL/6 mice both with and
without NIR treatment and did not exhibit any significant effect
compared to mice that did not receive mannitol. Pharmacological
inhibition of eNOS was used to complement the experiments in
eNOS−/− mice and thus, C57BL/6 mice received 1mg/kg, i.v. of
the non-selective NOS inhibitor L-NAME prior to LAD occlusion
and reperfusion.
DETERMINATION OF MYOCARDIAL INFARCT SIZE
For infarct size measurements, the heart was first stained
by cannulation of the aorta with a 1 % solution of 2,3,5-
triphenytetrazolium chloride. Then the suture previously placed
around the left descending coronary artery was retied and diluted
phthalo blue dye was injected through the same cannula. As a
result of these procedures, the non-ischemic portion of the left
ventricle was stained dark blue. Viable myocardium within the
area at risk was stained bright red, and infarcted tissue was light
yellow. The heart was then excised and ventricles were cut into
4–5 uniform transverse slices of 2mm thickness using a mouse
heart matrix. Slices were then analyzed by planimetry.
NITROSYL HEMOGLOBIN (HbNO) AND NITROSYL MYOGLOBIN (MbNO)
PREPARATION
Oxyhemoglobin purified from human blood according to a pub-
lished procedure (Rossi-Fanelli et al., 1961) was deoxygenated, or
solution of metmyoglobin (from horse skeletal muscle, Sigma)
was reduced in an anaerobic chamber with Na2S2O4 in phos-
phate buffered saline (PBS, pH 7.4). Then the heme proteins
were nitrosylated by addition of equivalent concentration of
highly concentrated PROLI NONOate (Cayman Chemicals, Ann
Frontiers in Physiology | Mitochondrial Research August 2014 | Volume 5 | Article 305 | 2
Keszler et al. Near infrared light induced-cardioprotection
Arbor, Mi) dissolved in 0.1N NaOH. The process was spec-
trophotometrically followed. Solutions were made daily, and used
immediately.
NO-DEPENDENT CHEMILUMINESCENCE ANALYSIS
A Sievers 280i Nitric Oxide Analyzer (General Electric, Boulder,
CO) was used to detect NO evolved from nitrosyl species as
a consequence of NIR irradiation. HbNO or MbNO (3ml of
10µM) was placed into the purge vessel of the analyzer, and
externally irradiated at various powers and wavelengths for 1min.
Detector response for NO liberated from known amounts of
PROLI NONOate injected into PBS pH 7.4 was used as a basis
of quantification.
MEASUREMENT OF OXYGEN CONSUMPTION IN ISOLATED
MITOCHONDRIA
Rat heart mitochondria were isolated by differential centrifuga-
tion as previously reported (Pravdic et al., 2010). Mitochondrial
oxygen consumption was measured with a Clark-type oxygen
electrode (Hansatech Instruments, Norfolk, UK) at 30 ◦C in
respiration buffer containing mitochondria at a final concentra-
tion of 1mg protein/mL. The mitochondrial respiration buffer
was composed of 130mM KCl, 5mM KH2PO4, 20mM MOPS,
2.5mM EGTA, 1mMNa4P2O7, and 0.1 % BSA, at pH 7.4. State 2
respiration was initiated with 5mM pyruvate and 5mMmalate as
substrates. The adenosine diphosphate (ADP)-stimulated oxygen
consumption (state 3 respiration) was measured in the presence
of 250µM ADP. After hypoxia was reached mitochondria were
incubated with deoxymyoglobin (40µM; prepared from myo-
globin with sodium dithionite as reducing agent) and sodium
nitrite (20µM) for 1min and then exposed directly to NIR
(170mW/cm2) for another min. After that the chamber was
opened to allow reoxygenation. A faster rate of reoxygenation of
the chamber indicated an inhibition of respiration.
STATISTICAL ANALYSIS
Statistical analysis of data within and between groups was per-
formed with analysis of variance (ANOVA) for repeated mea-
sures followed by the Student-Newman-Keuls test. Changes were
considered statistically significant when P < 0.05. All data are
expressed as mean ± standard deviation (SD) unless otherwise
indicated.
RESULTS
The mouse was chosen as model to determine the efficacy of
NIR-mediated protection against cardiac ischemia and reperfu-
sion injury in order to expand our findings on NIR-induced
protection in rabbits and due to the advantage of the large avail-
ability of genetically engineered animals. Exposure to NIR for the
last min of occlusion and first 4min of reperfusion significantly
(P < 0.05) reduced infarct size at the highest chosen irradiance
(170mW/cm2, corresponding to 51 J/cm2) compared to control
experiments without NIR exposure (31 ± 7 vs. 51 ± 4 % of left
ventricular area of risk, Figure 1). The effect of NIR on infarct size
was energy dependent. Myocardial infarct size was 59 ± 5 and 39
± 6 %, at an irradiance of 10 and 27mW/cm2, corresponding
to 3 and 8.1 J/cm2 respectively. Thus, the threshold of cardiopro-
tection appeared to occur at an irradiance level of 30mW/cm2.
FIGURE 1 | The NIR-mediated cardioprotection is irradiance-dependent.
The exposed mouse heart was irradiated at 670 nm with various irradiances
for 1min during ischemia and 4min during reperfusion. The lamp was
placed 5mm above the heart. At 170mW/cm2 a significant decrease in
infarct size was observed. Values are means ± SD, ∗p < 0.05 compared to
untreated control (CON).
FIGURE 2 | The NIR-mediated cardioprotection is NOS-independent.
The exposed heart of wild type and eNOS−/− mice was irradiated at 670 nm
with 170mW/cm2 power for 1min during ischemia, and 4min during
reperfusion. Mice treated with L-NAME (10mg/kg, administered 10min
prior occlusion) were also examined. Irradiation was equally protective in the
case of control, L-NAME-treated, and eNOS−/− mice. Values are means ±
SD, ∗p < 0.05 when compared to untreated control (CON).
Importantly, no increase in epicardial surface temperature upon
exposure to NIR was observed.
We then tested whether NOS is involved in the mechanism
of NIR-induced protection. Pretreatment with the non-selective
NOS inhibitor L-NAME had no effect alone (60 ± 6 % infarct
size of area at risk), nor did it inhibit NIR-mediated reduction in
infarct size (42 ± 5 %). Similarly, eNOS−/− mice were also pro-
tected against myocardial ischemia and reperfusion injury by NIR
treatment (44 ± 5 % compared to 59 ± 4 % without treatment).
An irradiance of 170mW/cm2 was applied in all cases. These data
suggest that NIR-mediated cardioprotection is independent of the
activity of NOS (Figure 2).
We recently reported (Lohr et al., 2009) that NIR light
has the capacity to liberate NO from nitrosylated hemoglobin
(HbNO) and myoglobin (MbNO). Here we examined the wave-
length dependence of NO release and protection. A solution of
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HbNO or MbNO (10µM) was placed into the purge vessel of
a chemiluminescence-based NO analyzer and subjected to irra-
diation for 1min. We observed 2–3 times more NO released
at 670 nm compared to 740 and 830 nm at 10mW/cm2 irradi-
ance (Figure 3A). As NIR does not have to penetrate tissue in
these experiments, less irradiance compared to what is required
for protection of the in vivo heart is needed. There was no
significant difference between NO liberation from HbNO and
MbNO. A similar trend was found with the wavelength depen-
dence of NIR-induced reduction of infarct size. In contrast to
670 nm no significant protection was observed at 740 and 830 nm
(Figure 3B).
Mitochondria are a potential therapeutic target of NO
produced at the time of reoxygenation (Chouchani et al.,
2013). Therefore, experiments were designed to establish the
net outcome of NIR-enhanced nitrite reductase activity on
mitochondrial respiration after hypoxia. We measured the reoxy-
genation rate of a mitochondrial suspension after hypoxia in
the presence of deoxymyoglobin and nitrite, with and without
NIR (660 nm, 50mW/cm2) (Figure 4). While Mb and nitrite
induce inhibition of mitochondrial respiration alone (Shiva et al.,
FIGURE 3 | Wavelength-dependence of NIR-induced NO release is in
accordance with wavelength dependence of cardioprotection. (A) A
solution of HbNO or MbNO (10µM in PBS, pH 7.4) was irradiated at various
wavelengths with 10mW/cm2 power for 1min in the chamber of the NO
analyzer. Formation of NO was on-line detected with ozone-based
chemiluminescence. Maximum NO liberation was achieved at 660 nm
irradiation with both heme nitrosyl compounds. Values are means ± SE,
n = 3. (B) The exposed heart was irradiated at various wavelengths
at170mW/cm2 irradiance for 1min during ischemia, and 4min during
reperfusion. Irradiation at 670 nm was the most cardioprotective. Values are
means ± SD, ∗p < 0.05 when compared to untreated control (CON).
2007a,b; Hendgen-Cotta et al., 2008), we hypothesized that light
enhances this inhibition through its action on MbNO formed as
a consequence of nitrite reductase activity of heme. We found
that NIR, while alone had no considerable effect, could poten-
tiate the inhibition caused by Mb and nitrite at lower nitrite
doses. It triggered a significantly faster reoxygenation and thereby
a decrease in respiration rate in the presence of deoxymyoglobin
and nitrite than solely deoxymyoglobin and nitrite would induce.
A partial compensatory effect of NO bound to and released from
complex IV cannot be excluded, however, in the investigated
in vitro system Mb was present in wide excess over cyt c oxi-
dase (0.64mg/ml Mb vs. 1mg/ml total mitochondrial protein),
and NIR was switched off at the time of reoxygenation. Thus,
NO released from Mb might partially bind to cytochrome c oxi-
dase or mediate S-nitrosation of complex I at the beginning of
reoxygenation, thereby accelerating reoxygenation and inhibiting
respiration. The observed effect is relevant since a mild reversible
inhibition of the mitochondrial electron transport chain during
cardiac reperfusion has been shown to reduce reactive oxygen
FIGURE 4 | NIR slows mitochondrial respiration in the presence of
deoxymyoglobin and nitrite during reoxygenation. (A) Oxygen
consumption of purified cardiac mitochondria was monitored with a
Clarke-type oxygen electrode. At the beginning of ischemia, deoxyMb and
sodium nitrite were added. During the second minute of ischemia before
reoxygenation, mitochondria were exposed to NIR at 670 nm with
50mW/cm2 irradiance. (B) NIR caused an NO-dependent increase of
reoxygenation rate (corresponding to a decrease of respiration) in the
presence of deoxyMb and nitrite. The effect was reversed with NO
scavenger CPTIO. Values are means ± SD, n = 6, ∗p < 0.05 when
compared to control, #p < 0.05 when compared to NIR treated
mitochondria in the absence of CPTIO.
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species production. In the presence of NO scavenger cPTIO
(10µM), the NIR effect was reversed.
In diabetes, endothelial dysfunction, including defective NOS,
is considered one of the causes for the failure of protective strate-
gies such as ischemic or anesthetic pre- and postconditioning
to reduce cardiac ischemia and reperfusion injury. Therefore, a
NOS-independent mechanism of NO generation may allow NIR
to reduce ischemia and reperfusion injury in the hyperglycemic
or diabetic heart. Indeed, a similar degree of NIR-induced car-
dioprotection was observed in mice that were exposed to acute
hyperglycemia (39 ± 4 % myocardial infarct size of area at risk
vs. 52 ± 2 % without NIR) and in the diabetic db/db mouse
(43 ± 4 vs. 61 ± 3 %) compared to the wild type mice (41 ± 3 %
vs. 56 ± 3 %).
DISCUSSION
The current results demonstrate that a brief exposure to NIR
immediately before and during early reperfusion protects the
myocardium against infarction in an NOS-independent mecha-
nism. Mitochondria are one potential therapeutic target of NIR-
induced release of NO but other targets such as NO-sensitive
guanylyl cyclase require further investigation. Importantly, NIR
protects the hyperglycemic and diabetic heart. The absence
of such protections has been one of the major hurdles in
the implementation of pharmacological pre- and particularly
postconditioning into the clinical setting.
In the nineteen nineties in Russia patients with coronary heart
disease with prior myocardial infarction were exposed repeat-
edly to NIR by low-level laser therapy (LLLT) applied to the
area of the heart on the skin. Lipid peroxidation was signifi-
cantly reduced after NIR but little is known on whether cardiac
function improved (Zubkova et al., 1993; Sorokina et al., 1997).
In subsequent studies NIR was applied after chronic myocardial
infarction in rat and dog models. NIR (803 nm, 6mW/cm2 at the
surface of the myocardium for 3min, at 4-6 different locations)
was applied twice, 15min and 3 days after myocardial infarction,
through the open chest directly onto the myocardium in dogs,
and through the intercostal muscles in rats. Both mortality and
infarct size were significantly reduced compare to untreated ani-
mals (Oron et al., 2001). Irradiation with NIR after myocardial
infarction in rats resulted in a significant improved mitochon-
drial bioenergetics, and an increase in an inducible heat shock
protein (HSP70), vascular endothelial growth factor (VEGF) and
inducible nitric oxide synthase (iNOS) expression (Yaakobi et al.,
2001). This was paralleled by a significant elevation in angio-
genesis (Tuby et al., 2006). More recently, increased angiogenesis
and collateralization upon NIR exposure (670 nm, 50mW/cm2,
10min per day for 14 days) with LED have also been reported
in the ischemic hind limb of mice and rabbits (Lohr et al.,
2013). In a mouse model for systemic sclerosis, an autoim-
mune connective tissue disorder characterized by oxidative stress,
impaired vascular function, and attenuated angiogenesis, NIR
stimulated angiogenesis by increasing angiomotin and decreas-
ing angiostatin expression in the ischemic hind limb (Zaidi et al.,
2013).
In the present study we found that myocardial infarction can
be prevented from occurring, or at least reduced by a one-time
NIR treatment right at the time of reoxygenation. It appears
highly unlikely that NIR-induced reductions in infarct size were
attributed to increased collateral perfusion as NIR-induced angio-
genesis typically occurs as a result of sustained stimulation over
several days. Therefore, the underlying mechanism of protection
is likely different. Under hypoxic conditions heme-containing
proteins such as myoglobin (Mb) and hemoglobin (Hb) exhibit
nitrite reductase activity which results in an increase in NO
liberation (Gladwin et al., 2006; Hendgen-Cotta et al., 2008). The
NO formed may subsequently react with available deoxyHb or
deoxyMb to yield iron-nitrosyl Hb (HbNO) or iron-nitrosyl Mb
(MbNO). Thus, HbNO and MbNO may represent a significant
storage pool of NO in the heart. Here we have demonstrated
both for purified hemoglobin and myoglobin that NIR can decay
nitrosyl heme and release NO in a wavelength-dependent man-
ner. Importantly, the highest NO release was recorded at 670 nm
where protection against ischemia and reperfusion injury was
present (Figure 3). This further suggests a distinct mechanism
from the previously reported protection through repeated NIR
treatment in the permanently ligated heart where longer wave-
lengths were equally protective. We previously reported in the
ischemic rabbit heart, after infusion of sodium nitrite, a large
increase in nitrosyl heme formation as measured by electro para-
magnetic resonance spectroscopy (EPR). The MbNO signal was
reduced in the ischemic zone by NIR treatment suggesting dis-
sociation of the heme-NO bond upon irradiation (Lohr et al.,
2009).
Frequently, the beneficial effects of NIR treatment have been
associated with the stimulation of mitochondrial metabolism,
particularly at the level of cytochrome c oxidase, complex IV of
the electron transport chain and concomitant enhancement of
ATP synthesis (Karu, 2008). NIR may directly affect cytochrome
c oxidase activity through one of its redox active metal cen-
ters. In addition, it has been suggested that NIR exerts its action
on cytochrome c oxidase by a mechanism via NO release. The
activated cytochrome c oxidase may not only cause changes in
electron transport chain activity, including ROS generation, but
released NO is available for other biological processes such as
vasodilation and gene expression. However, compared to poten-
tial NO release from HbNO or MbNO the relative amounts of
NO in the case of cyt c oxidase is limited (Osipov et al., 2007).
Further, it is difficult to perceive how acceleration of cytochrome c
oxidase at the time of reperfusion conveys protection to the heart.
Rather, a mild reversible inhibition of the electron transport chain
has been shown to reduce reactive oxygen species production
during reperfusion and increase cardiomyocyte survival (Burwell
et al., 2009). This was confirmed in ischemic isolated mito-
chondria where, in the presence of deoxmyoglobin and sodium
nitrite, a decrease in respiration was detected upon reoxygena-
tion of mitochondria after application of NIR (Figure 4). NO
signaling may lead to S-nitrosation of a cysteine residue in com-
plex I that has been implicated in protection against cardiac
ischemia and reperfusion injury (Cochain et al., 2013). Reversible
S-nitrosation of complex I slows the reactivation of mitochondria
during the crucial first minutes of the reperfusion of ischemic tis-
sue, thereby decreasing ROS production, oxidative damage and
tissue necrosis.
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FIGURE 5 | NIR is cardioprotective in the presence of diabetes or
hyperglycemia. The exposed heart of wild type, db/db, and hyperglycemic
mice was irradiated at 670 nm with 170mW/cm2 irradiance for 1min during
ischemia, and 4min during reperfusion. Light exposure resulted in a
similarly effective decrease of infarct size in all three cases. Values are
means ± SD, ∗p < 0.05 when compared to untreated wild type.
Due to the reasonably high tissue penetration paralleled by
limited potential of tissue damage NIR is attractive for the use
in ischemic heart disease. While the required light power needs to
be verified for human cardiac use, by comparing animal studies
through various species and experimental settings an irradiance
of 10–100mW/cm2 for 2–10min seems a reasonable starting
point to achieve beneficial effects of NIR. A higher irradiance
may be required for acute prevention of ischemia and reper-
fusion injury at the time of reperfusion. NIR treatment of the
heart may be protective on patients after acute myocardial infarc-
tion or on ischemic heart conditions that are not accessible
to current revascularization procedures. NIR could be particu-
larly useful in the presence of comorbidities such as diabetes.
Diabetes is an independent predictor of increased cardiovascular
risk and myocardial infarct size is directly related to increases in
blood glucose concentration in animals with or without diabetes
(Van Der Horst et al., 2007). The mechanism of light-induced
release of NO from iron-nitrosylated heme protein is likely to
be maintained during diabetes and thus NIR may be protective
from ischemia and reperfusion injury where other strategies such
as ischemic and pharmacologic pre- and postconditioning fail
(Kersten et al., 1998; Przyklenk et al., 2011). Indeed, we found
that under acute hyperglycemia or in a mouse model of type 2
diabetes (db/db mouse) NIR exposure of the mouse heart at the
time of reperfusion reduces infarct size significantly (Figure 5).
While there is substantial clinical promise for the use of NIR
in heart disease several hurdles need to be considered and over-
come. The technical challenge related to the application of NIR to
the heart due to limited penetration through muscle and bone
is an important issue to consider. Obvious scenarios would be
application of light where needed during cardiac surgery such
as coronary artery bypass that carry a significant increased risk
of myocardial infarction, or heart transplantation. It might also
be possible to apply NIR during a balloon angiography, using a
catheter bearing fiber optic through which the light can be deliv-
ered to the infarcted area. In addition, authors’ unpublished data
on dogs demonstrate the feasibility of a transesophageal approach
to the heart with a flexible fiber optic NIR probe. The probe in
the esophagus or stomach (when advanced) is immediately adja-
cent to the left atrium and the inferior and posterior walls of the
left ventricle. Thus, the anterior wall that is frequently affected
by myocardial infarction may be as much as 6 cm away from the
probe. Still, it may not be necessary for NIR light to penetrate
the area at risk directly. A remote effect of NIR, comparable to
remote preconditioning, might still provide protection and lead
to a reduction of infarct size. Signaling factors such as heat shock
proteins or NO may mediate such effect.
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